Steven R. S. Coffey - 18 Mar 2026 Form 3 Insider Report for KAZIA THERAPEUTICS LTD (KZIA)

Role
Director
Signature
/s/ Jeffrey Bonacorda, Attorney-in-Fact
Issuer symbol
KZIA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 19:18:21 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coffey Steven R. S. Director THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO AVE, SYDNEY, NSW, AUSTRALIA /s/ Jeffrey Bonacorda, Attorney-in-Fact 18 Mar 2026 0002121676

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KZIA Ordinary Shares 16,000 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KZIA American Depositary Share Option (Right to Buy) 18 Mar 2026 American Depositary Shares 1,000 $0.3348 Direct F1, F2, F3
holding KZIA American Depositary Share Option (Right to Buy) 18 Mar 2026 American Depositary Shares 75,000 $8.00 Direct F2, F3, F4
holding KZIA American Depositary Shares 18 Mar 2026 Ordinary Shares 845 See footnote F3, F5
holding KZIA American Depositary Shares 18 Mar 2026 Ordinary Shares 1,122 See footnote F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The American Depositary Shares ("ADSs") subject to the option ("ADS option") vest in equal quarterly installments over three years beginning on April 30, 2024, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The ADS option was granted on April 30, 2024.
F2 Each ADS option is convertible into ADSs upon exercise.
F3 Each ADS may be represented by 500 ordinary shares of the Issuer, no par per share (the "Ordinary Shares"), at any time, upon the holder's election to surrender the ADSs and withdraw the respective number of Ordinary Shares. The ADSs have no expiration date.
F4 The ADSs subject to the ADS option vested as to 100% on July 3, 2025. The ADS option was granted on July 3, 2025.
F5 The ADSs are held directly by Coffey Family Investments Pty Limited, of which the Reporting Person is a director. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F6 The ADSs are held directly by Fortune 501 Pty Limited. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 3 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit 24 - Power of Attorney